Deutsche Bank’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-14,755
| Closed | -$274K | – | 3793 |
|
|
2023
Q3 | $274K | Sell |
14,755
-7,744
| -34% | -$87.6K | ﹤0.01% | 2573 |
|
|
2023
Q2 | $249K | Sell |
22,499
-242,558
| -92% | -$3.38M | ﹤0.01% | 2761 |
|
|
2023
Q1 | $3.56M | Buy |
265,057
+173,832
| +191% | +$3.01M | ﹤0.01% | 1382 |
|
|
2022
Q4 | $1.13M | Buy |
91,225
+8,354
| +10% | +$118K | ﹤0.01% | 1976 |
|
|
2022
Q3 | $1.16M | Buy |
82,871
+18,111
| +28% | +$292K | ﹤0.01% | 1880 |
|
|
2022
Q2 | $894K | Buy |
64,760
+49,519
| +325% | +$793K | ﹤0.01% | 2257 |
|
|
2022
Q1 | $248K | Sell |
15,241
-2,092
| -12% | -$32.8K | ﹤0.01% | 3138 |
|
|
2021
Q4 | $282K | Sell |
17,333
-8,449
| -33% | -$142K | ﹤0.01% | 3189 |
|
|
2021
Q3 | $382K | Sell |
25,782
-92,727
| -78% | -$1.48M | ﹤0.01% | 3208 |
|
|
2021
Q2 | $2.37M | Buy |
118,509
+90,394
| +322% | +$1.79M | ﹤0.01% | 2077 |
|
|
2021
Q1 | $648K | Sell |
28,115
-44,865
| -61% | -$1.25M | ﹤0.01% | 2937 |
|
|
2020
Q4 | $1.8M | Sell |
72,980
-236,009
| -76% | -$7.82M | ﹤0.01% | 1996 |
|
|
2020
Q3 | $12.8M | Buy |
308,989
+826
| +0.3% | +$38K | 0.01% | 867 |
|
|
2020
Q2 | $14.8M | Sell |
308,163
-52,797
| -15% | -$4.08M | 0.01% | 816 |
|
|
2020
Q1 | $22.7M | Sell |
360,960
-131,518
| -27% | -$11.8M | 0.02% | 606 |
|
|
2019
Q4 | $61M | Buy |
492,478
+146,920
| +43% | +$13.2M | 0.04% | 430 |
|
|
2019
Q3 | $22.9M | Sell |
345,558
-126,283
| -27% | -$8.48M | 0.02% | 733 |
|
|
2019
Q2 | $37.5M | Buy |
471,841
+85,683
| +22% | +$7.67M | 0.02% | 686 |
|
|
2019
Q1 | $43.2M | Buy |
386,158
+16,539
| +4% | +$1.81M | 0.03% | 634 |
|
|
2018
Q4 | $37.3M | Sell |
369,619
-113,555
| -24% | -$11.8M | 0.03% | 613 |
|
|
2018
Q3 | $61.1M | Buy |
483,174
+119,529
| +33% | +$12.6M | 0.03% | 572 |
|
|
2018
Q2 | $30.5M | Buy |
363,645
+75,042
| +26% | +$5.49M | 0.02% | 923 |
|
|
2018
Q1 | $17.8M | Buy |
288,603
+131,177
| +83% | +$7.91M | 0.01% | 1191 |
|
|
2017
Q4 | $9.19M | Sell |
157,426
-53,650
| -25% | -$3.38M | 0.01% | 1563 |
|
|
2017
Q3 | $12.2M | Buy |
211,076
+27,198
| +15% | +$2.93M | 0.01% | 1312 |
|
|
2017
Q2 | $22.3M | Buy |
183,878
+6,434
| +4% | +$745K | 0.02% | 889 |
|
|
2017
Q1 | $20.1M | Sell |
177,444
-4,539
| -2% | -$530K | 0.01% | 877 |
|
|
2016
Q4 | $19.8M | Sell |
181,983
-39,333
| -18% | -$4.69M | 0.02% | 866 |
|
|
2016
Q3 | $36.4M | Sell |
221,316
-29,605
| -12% | -$4.67M | 0.03% | 654 |
|
|
2016
Q2 | $35.8M | Buy |
250,921
+100,501
| +67% | +$14.7M | 0.03% | 643 |
|
|
2016
Q1 | $19.3M | Sell |
150,420
-41,574
| -22% | -$4.91M | 0.01% | 917 |
|
|
2015
Q4 | $28.7M | Buy |
191,994
+19,411
| +11% | +$3.29M | 0.02% | 771 |
|
|
2015
Q3 | $28.6M | Sell |
172,583
-3,738
| -2% | -$822K | 0.02% | 705 |
|
|
2015
Q2 | $42.6M | Buy |
176,321
+42,870
| +32% | +$11.4M | 0.03% | 599 |
|
|
2015
Q1 | $37.6M | Buy |
133,451
+86,628
| +185% | +$18.8M | 0.02% | 647 |
|
|
2014
Q4 | $7.3M | Buy |
46,823
+28,915
| +161% | +$5.34M | ﹤0.01% | 1664 |
|
|
2014
Q3 | $4.24M | Buy |
17,908
+1,143
| +7% | +$291K | ﹤0.01% | 1959 |
|
|
2014
Q2 | $3.96M | Buy |
16,765
+8,926
| +114% | +$2.35M | ﹤0.01% | 1993 |
|
|
2014
Q1 | $2.58M | Buy |
7,839
+6,422
| +453% | +$2.17M | ﹤0.01% | 2236 |
|
|
2013
Q4 | $96K | Sell |
1,417
-7,597
| -84% | -$439K | ﹤0.01% | 4077 |
|
|
2013
Q3 | $621K | Buy |
9,014
+4,543
| +102% | +$224K | ﹤0.01% | 3332 |
|
|
2013
Q2 | $199K | Buy |
+4,471
| New | +$153K | ﹤0.01% | 3829 |
|
Deutsche Bank's ICPT Position: Q4 2023 in Review
Deutsche Bank sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 14,755 shares — an estimated $274K sold.
Deutsche Bank first reported a position in ICPT in Q2 2013 and held it in 42 quarters. The position peaked at $61.1M in Q3 2018. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Deutsche Bank reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Deutsche Bank sold 14,755 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $274K.
- Deutsche Bank first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 42 quarters.
- Deutsche Bank's Intercept Pharmaceuticals, Inc. position peaked at $61.1M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Deutsche Bank's 13F filing for Q4 2023, filed 14 Feb 2024.